Sickle Cell Disease Comprehensive Care Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Dec 9, 2021)
Sickle Cell Disease Comprehensive Care Act
This bill establishes and provides funds for a demonstration project for state Medicaid programs to improve outpatient care for individuals with sickle cell disease, with a focus on young adults and pregnant women.
The Centers for Medicare & Medicaid Services must award planning grants to at least 10 states and must select between 5 and 10 states to participate in the project. Participating states must provide specified services and support for individuals with sickle cell disease, including multidisciplinary care teams, appropriate treatments, mental health services, and specialist services.
The bill provides a 100% Federal Medical Assistance Percentage (i.e., federal matching rate) for services provided through the project.
What just happenedDec 10, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseDec 9, 2021
- Dec 10, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Dec 9, 2021IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Dec 9, 2021IntroReferralIntro-H
Introduced in House
- Dec 9, 2021IntroReferral1000
Introduced in House